← Back to dossier
Patient handout

Sickle Cell Disease (chronic management + acute crisis)

PRODUCTION

1. Your condition

This handout is for sickle cell disease (chronic management + acute crisis). Your care team identified this based on: vaso-occlusive pain crisis (ash 2020; nhlbi 2014).

Other reasons your team may use this plan: fever in scd (functional asplenia — sepsis until proven otherwise) (ash 2020); chest pain / dyspnea / hypoxia → acs workup (ash 2020); priapism >4h (ash 2020).

2. Your medications

Take these medications exactly as prescribed. Do not stop or change a dose without talking to your provider.

MedicationStarting doseHowWhenWhat it does
hydroxyureaMSH NEJM 1995; BABY HUG; ASH 2020; foundation of DMT
l_glutamineBEACON NEJM 2018
crizanlizumabSUSTAIN NEJM 2017 — STAND phase 3 FAILED; EU/UK revoked 2023–2024; clinical benefit questioned
exa_cel_casgevyFDA approval Dec 2023; one-time CRISPR-edited autologous HSC
lovo_cel_lyfgeniaFDA approval Dec 2023; lentiviral β-globin

Plan: Disease-modifying therapy (chronic)

3. Your action plan

Use these zones to know what to do based on how you feel.

GREENStable — feeling well
If you have:
  • No pain or pain at baseline (ASH 2020)
  • No fever (ASH 2020)
  • Eating and drinking well (NHLBI 2014)
  • Taking hydroxyurea/L-glutamine as prescribed (ASH 2020)
Do this:
  • Continue hydroxyurea/L-glutamine as prescribed (ASH 2020)
  • Stay well hydrated (3-4 L/day for adults) (NHLBI 2014)
  • Avoid extreme cold, high altitude, dehydration (NHLBI 2014)
  • Continue penicillin (peds) and all vaccinations (NHLBI 2014; NASCC 2024)
  • Keep all clinic appointments (NASCC 2024)
YELLOWCaution — early crisis warning
If you have:
  • Mild pain in usual sites (legs, back, chest, abdomen) (NHLBI 2014)
  • Fatigue more than usual (NHLBI 2014)
  • Decreased appetite (NHLBI 2014)
  • Slight fever (<38.5 C) (ASH 2020)
  • Mild URI symptoms (ASH 2020)
Do this:
  • Increase fluids (NHLBI 2014)
  • Take home pain regimen as prescribed (NSAIDs cautiously, opioids per home plan) (NHLBI 2014)
  • Continue all baseline medications (ASH 2020)
  • Use heat packs to affected areas (NHLBI 2014)
  • Call SCD clinic within 4-8 hours (ASH 2020)
  • If home regimen ineffective in 4 hours → ED (ASH 2020)
Call your provider if:
  • Pain not controlled with home regimen (NHLBI 2014)
  • Persistent fever (ASH 2020)
  • Cough or shortness of breath (ASH 2020)
  • Decreased urine output (NHLBI 2014)
REDMedical alert — go to ED now
If you have:
  • Severe pain not controlled by home regimen (ASH 2020)
  • Fever ≥38.5 C (ASH 2020; NHLBI 2014)
  • Chest pain or trouble breathing (ASH 2020)
  • Acute neurologic symptoms (weakness, slurred speech, confusion, vision changes) (ASH 2020)
  • Priapism (sustained erection >2 hours) (ASH 2020)
  • Severe abdominal pain or sudden splenic enlargement (NHLBI 2014)
  • Sudden worsening of anemia (severe pallor, dizziness) (NHLBI 2014)
Do this:
  • Go to ED immediately (ASH 2020)
  • Transfer criteria — request transfer to SCD-specialized center if local ED limited (ASH 2020)
  • Bring home medication list and last clinic notes (ASH 2020)
  • Tell ED you have SCD genotype (HbSS/HbSC/HbS-beta-zero/HbS-beta-plus) (ASH 2020)
  • Request hematology consult (ASH 2020)
Call your provider if:
  • Any red zone symptom — go to ED immediately (ASH 2020)

4. When to seek emergency care

Call 911 or go to the nearest emergency room right away if you have:

  • Temperature ≥38.5°C in SCD patient (ASH 2020; NHLBI 2014)
  • Fever + cough/dyspnea/hypoxia + new pulmonary infiltrate (ASH 2020)(life-threatening)
  • Acute neurologic deficit in SCD patient (ASH 2020)(life-threatening)
  • Sustained priapism >4 hours (ASH 2020)
  • Acute Hb drop >2 below baseline + splenomegaly + pancytopenia/cytopenia (NHLBI 2014)
  • Hb drop with absolute reticulocyte count <1% (NHLBI 2014)
  • Acute organ dysfunction in 2+ systems during VOC (ASH 2020)(life-threatening)

5. Follow-up

Health maintenance per NASCC 2024: vaccinations (penicillin prophylaxis ages <5), TCD, retinopathy screen, baseline echo, contraception/pregnancy planning, cognitive assessment, transition to adult care

6. Sources

Guideline: ASH 2020 SCD Guidelines (multiple Blood Advances) + NHLBI 2014 + NASCC 2024 Health Maintenance + ASH 2025 draft hydroxyurea

  1. pubmed.ncbi.nlm.nih.gov/7715639
  2. pubmed.ncbi.nlm.nih.gov/9647873
  3. pubmed.ncbi.nlm.nih.gov/30021096